3 | SEC Filings Hub

Filing metadata

Accession number: 0001193125-26-036046
Form type: Form 3
Filer: AN2 Therapeutics, Inc.
CIK: CIK 1880438
Filed: Feb 03, 2026
Reporting period: Jan 26, 2026
Description: Initial ownership

Documents

0001193125-26-036046-index.htm

Complete submission

0001193125-26-036046.txt

directory listing

Filed by

AN2 Therapeutics, Inc.